Association Between Infection With <i>Helicobacter pylori</i> and <i>Chlamydia pneumoniae</i> and Risk of Ischemic Stroke Subtypes

  • Peter U. Heuschmann
    From the Unit for Stroke Research and Public Health Medicine, Department of Neurology (P.U.H., M.G., B.C., B.N., P.L.K-R.), Department of Pathology (D.N., G.F.), and Institute of Neurobiochemistry, Department of Psychiatry (G.B.), University of Erlangen; and Institute for Medical Microbiology and Hygiene, Medical University of Luebeck (M.M.) (Germany).
  • Daniel Neureiter
    From the Unit for Stroke Research and Public Health Medicine, Department of Neurology (P.U.H., M.G., B.C., B.N., P.L.K-R.), Department of Pathology (D.N., G.F.), and Institute of Neurobiochemistry, Department of Psychiatry (G.B.), University of Erlangen; and Institute for Medical Microbiology and Hygiene, Medical University of Luebeck (M.M.) (Germany).
  • Markus Gesslein
    From the Unit for Stroke Research and Public Health Medicine, Department of Neurology (P.U.H., M.G., B.C., B.N., P.L.K-R.), Department of Pathology (D.N., G.F.), and Institute of Neurobiochemistry, Department of Psychiatry (G.B.), University of Erlangen; and Institute for Medical Microbiology and Hygiene, Medical University of Luebeck (M.M.) (Germany).
  • Benjamin Craiovan
    From the Unit for Stroke Research and Public Health Medicine, Department of Neurology (P.U.H., M.G., B.C., B.N., P.L.K-R.), Department of Pathology (D.N., G.F.), and Institute of Neurobiochemistry, Department of Psychiatry (G.B.), University of Erlangen; and Institute for Medical Microbiology and Hygiene, Medical University of Luebeck (M.M.) (Germany).
  • Matthias Maass
    From the Unit for Stroke Research and Public Health Medicine, Department of Neurology (P.U.H., M.G., B.C., B.N., P.L.K-R.), Department of Pathology (D.N., G.F.), and Institute of Neurobiochemistry, Department of Psychiatry (G.B.), University of Erlangen; and Institute for Medical Microbiology and Hygiene, Medical University of Luebeck (M.M.) (Germany).
  • Gerhard Faller
    From the Unit for Stroke Research and Public Health Medicine, Department of Neurology (P.U.H., M.G., B.C., B.N., P.L.K-R.), Department of Pathology (D.N., G.F.), and Institute of Neurobiochemistry, Department of Psychiatry (G.B.), University of Erlangen; and Institute for Medical Microbiology and Hygiene, Medical University of Luebeck (M.M.) (Germany).
  • Georg Beck
    From the Unit for Stroke Research and Public Health Medicine, Department of Neurology (P.U.H., M.G., B.C., B.N., P.L.K-R.), Department of Pathology (D.N., G.F.), and Institute of Neurobiochemistry, Department of Psychiatry (G.B.), University of Erlangen; and Institute for Medical Microbiology and Hygiene, Medical University of Luebeck (M.M.) (Germany).
  • Bernhard Neundoerfer
    From the Unit for Stroke Research and Public Health Medicine, Department of Neurology (P.U.H., M.G., B.C., B.N., P.L.K-R.), Department of Pathology (D.N., G.F.), and Institute of Neurobiochemistry, Department of Psychiatry (G.B.), University of Erlangen; and Institute for Medical Microbiology and Hygiene, Medical University of Luebeck (M.M.) (Germany).
  • Peter L. Kolominsky-Rabas
    From the Unit for Stroke Research and Public Health Medicine, Department of Neurology (P.U.H., M.G., B.C., B.N., P.L.K-R.), Department of Pathology (D.N., G.F.), and Institute of Neurobiochemistry, Department of Psychiatry (G.B.), University of Erlangen; and Institute for Medical Microbiology and Hygiene, Medical University of Luebeck (M.M.) (Germany).

書誌事項

タイトル別名
  • Results From a Population-Based Case-Control Study

この論文をさがす

抄録

<jats:p> <jats:bold> <jats:italic> <jats:bold> <jats:italic>Background and Purpose</jats:italic> </jats:bold> — </jats:italic> </jats:bold> <jats:italic>Helicobacter pylori</jats:italic> and <jats:italic>Chlamydia pneumoniae</jats:italic> have been associated epidemiologically and pathogenetically with coronary atherosclerosis. However, population-based data on chronic infection and stroke are lacking. Therefore, we investigated the association of both bacterial pathogens and ischemic stroke subtypes in a population-based case-control study. </jats:p> <jats:p> <jats:bold> <jats:italic> <jats:bold> <jats:italic>Methods</jats:italic> </jats:bold> — </jats:italic> </jats:bold> Patients with first ischemic stroke in the population-based Erlangen Stroke Project were collected as cases. Neighborhood controls were drawn from the study population, matched for age, sex, and place of residence. IgG antibodies to <jats:italic>H pylori</jats:italic> were measured by enzyme immunoassay, and IgG antibodies to <jats:italic>C pneumoniae</jats:italic> were measured by microimmunofluorescence technique. Conditional logistic regression was used. Analyses were stratified for etiologic stroke subtypes according to Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria. </jats:p> <jats:p> <jats:bold> <jats:italic> <jats:bold> <jats:italic>Results</jats:italic> </jats:bold> — </jats:italic> </jats:bold> A total of 145 case and 260 control subjects were included. Chronic <jats:italic>H pylori</jats:italic> infection was associated with a higher risk of stroke caused by small-artery occlusion (adjusted odds ratio, 3.31; 95% CI, 1.15 to 9.56) and a lower risk of cardioembolic stroke (adjusted odds ratio, 0.21; 95% CI, 0.06 to 0.71). Overall, elevated <jats:italic>H pylori</jats:italic> as well as elevated <jats:italic>C pneumoniae</jats:italic> antibodies were not associated with ischemic stroke. </jats:p> <jats:p> <jats:bold> <jats:italic> <jats:bold> <jats:italic>Conclusions</jats:italic> </jats:bold> — </jats:italic> </jats:bold> Our population-based study does not provide evidence of any strong association between the immune response to <jats:italic>C pneumoniae</jats:italic> as a marker of prior infection and ischemic stroke. Further studies are required to reveal the role of chronic <jats:italic>H pylori</jats:italic> infection as an independent risk factor for the subgroup small-artery occlusion. </jats:p>

収録刊行物

  • Stroke

    Stroke 32 (10), 2253-2258, 2001-10

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (6)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ